Cargando…

Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study

OBJECTIVES: Primary objective: to determine the point prevalence and incidence rate of severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in children aged 5–16 years over 13 months. Secondary objectives: to describe the demographic features, symptoms, impact on activities of daily li...

Descripción completa

Detalles Bibliográficos
Autores principales: Royston, Alexander Peter, Rai, Manmita, Brigden, Amberly, Burge, Sarah, Segal, Terry Y, Crawley, Esther M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985735/
https://www.ncbi.nlm.nih.gov/pubmed/36456114
http://dx.doi.org/10.1136/archdischild-2022-324319
_version_ 1784901021331357696
author Royston, Alexander Peter
Rai, Manmita
Brigden, Amberly
Burge, Sarah
Segal, Terry Y
Crawley, Esther M
author_facet Royston, Alexander Peter
Rai, Manmita
Brigden, Amberly
Burge, Sarah
Segal, Terry Y
Crawley, Esther M
author_sort Royston, Alexander Peter
collection PubMed
description OBJECTIVES: Primary objective: to determine the point prevalence and incidence rate of severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in children aged 5–16 years over 13 months. Secondary objectives: to describe the demographic features, symptoms, impact on activities of daily living, school attendance and time to diagnosis. DESIGN: Prospective surveillance study conducted by the British Paediatric Surveillance Unit. Paediatricians was asked if they had assessed a child with severe ME/CFS (screening definition for prevalence and incidence: children (5–16 years) diagnosed with ME/CFS so severe that they are unable to attend school for more than 1 hour a week during the last 6 weeks of the school term). PARTICIPANTS: Patients 5–16 years of age, seen by paediatricians and two large ME/CFS specialist services across the UK and Ireland. OUTCOME MEASURES: Paediatrician-completed questionnaires describing demographics, symptoms, function and treatment, (applying National Institute for Health and Care Excellence (NICE)-recommended criteria to assess severity of ME/CFS). Diagnosis of severe, probable severe or possible severe ME/CFS was made only with evidence of NICE-recommended screening blood tests. RESULTS: 285 cases were reported, of which of which 33 were severe, 4 probable severe and 55 possible severe. Estimated prevalence was 3.2 per million children (95% CI 2.2 to 4.5). Including possible/probable severe ME/CFS gave 8.9 per million children (95% CI 7.2 to 11). The incidence rate was 0.90 per million children-years (95% CI 0.43 to 1.65) (1.97 per million children-years (95% CI 1.24 to 2.99)). Median age was 13 years and 58% of cases were female. Median time to diagnosis was 0.47 years. CONCLUSIONS: Although the incidence of children presenting with severe ME/CFS is low, all were very disabled. In addition, the majority receive little or no education. Paediatricians need to consider how to provide rehabilitation and education for these disabled young people.
format Online
Article
Text
id pubmed-9985735
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-99857352023-03-06 Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study Royston, Alexander Peter Rai, Manmita Brigden, Amberly Burge, Sarah Segal, Terry Y Crawley, Esther M Arch Dis Child Original Research OBJECTIVES: Primary objective: to determine the point prevalence and incidence rate of severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in children aged 5–16 years over 13 months. Secondary objectives: to describe the demographic features, symptoms, impact on activities of daily living, school attendance and time to diagnosis. DESIGN: Prospective surveillance study conducted by the British Paediatric Surveillance Unit. Paediatricians was asked if they had assessed a child with severe ME/CFS (screening definition for prevalence and incidence: children (5–16 years) diagnosed with ME/CFS so severe that they are unable to attend school for more than 1 hour a week during the last 6 weeks of the school term). PARTICIPANTS: Patients 5–16 years of age, seen by paediatricians and two large ME/CFS specialist services across the UK and Ireland. OUTCOME MEASURES: Paediatrician-completed questionnaires describing demographics, symptoms, function and treatment, (applying National Institute for Health and Care Excellence (NICE)-recommended criteria to assess severity of ME/CFS). Diagnosis of severe, probable severe or possible severe ME/CFS was made only with evidence of NICE-recommended screening blood tests. RESULTS: 285 cases were reported, of which of which 33 were severe, 4 probable severe and 55 possible severe. Estimated prevalence was 3.2 per million children (95% CI 2.2 to 4.5). Including possible/probable severe ME/CFS gave 8.9 per million children (95% CI 7.2 to 11). The incidence rate was 0.90 per million children-years (95% CI 0.43 to 1.65) (1.97 per million children-years (95% CI 1.24 to 2.99)). Median age was 13 years and 58% of cases were female. Median time to diagnosis was 0.47 years. CONCLUSIONS: Although the incidence of children presenting with severe ME/CFS is low, all were very disabled. In addition, the majority receive little or no education. Paediatricians need to consider how to provide rehabilitation and education for these disabled young people. BMJ Publishing Group 2023-03 2022-12-01 /pmc/articles/PMC9985735/ /pubmed/36456114 http://dx.doi.org/10.1136/archdischild-2022-324319 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Royston, Alexander Peter
Rai, Manmita
Brigden, Amberly
Burge, Sarah
Segal, Terry Y
Crawley, Esther M
Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study
title Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study
title_full Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study
title_fullStr Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study
title_full_unstemmed Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study
title_short Severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a British Paediatric Surveillance Unit study
title_sort severe myalgic encephalomyelitis/chronic fatigue syndrome in children and young people: a british paediatric surveillance unit study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985735/
https://www.ncbi.nlm.nih.gov/pubmed/36456114
http://dx.doi.org/10.1136/archdischild-2022-324319
work_keys_str_mv AT roystonalexanderpeter severemyalgicencephalomyelitischronicfatiguesyndromeinchildrenandyoungpeopleabritishpaediatricsurveillanceunitstudy
AT raimanmita severemyalgicencephalomyelitischronicfatiguesyndromeinchildrenandyoungpeopleabritishpaediatricsurveillanceunitstudy
AT brigdenamberly severemyalgicencephalomyelitischronicfatiguesyndromeinchildrenandyoungpeopleabritishpaediatricsurveillanceunitstudy
AT burgesarah severemyalgicencephalomyelitischronicfatiguesyndromeinchildrenandyoungpeopleabritishpaediatricsurveillanceunitstudy
AT segalterryy severemyalgicencephalomyelitischronicfatiguesyndromeinchildrenandyoungpeopleabritishpaediatricsurveillanceunitstudy
AT crawleyestherm severemyalgicencephalomyelitischronicfatiguesyndromeinchildrenandyoungpeopleabritishpaediatricsurveillanceunitstudy